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Microfluidic generation of encapsulated droplet
interface bilayer networks (multisomes) and their
use as cell-like reactors†
Yuval Elani,*ab Xavier C. I. Solvas,‡a Joshua B. Edel,ab Robert V. Lawab and
Oscar Ces*ab
Compartmentalised structures based on droplet interface bilayers
(DIBs), including multisomes and compartmentalised vesicles, are
seen by many as the next generation of biomimetic soft matter
devices. Herein, we outline a microfluidic approach for the construc-
tion of miniaturised multisomes of pL volumes in high-throughput
and demonstrate their potential as vehicles for in situ chemical
synthesis.
Droplet interface bilayers (DIBs) are lipid membranes which are
formed when two lipid monolayer-coated water-in-oil droplets
are brought into contact.1 Oil is excluded from the interface
and a bilayer is formed. Critically, when three or more droplets
are joined together, a bilayer network can be generated.1–4 DIBs
are emerging as a new platform for the construction of soft
matter devices with incorporated biological functional compo-
nents, including protein pores (both natural and engineered),
enzymes, DNA, protein synthesis machinery and polymerisable
lipids.1,5–8 In this sense DIB devices can be considered to be a
sub-discipline in bottom-up synthetic biology, where functional
cell-like structures are constructed using simple chemical and
biological building blocks. To date, the power of DIB devices for
a range of applications has been demonstrated. They have been
shown to be capable of mimicking simple electrical circuits
and logic gates,3,9 acting as biobatteries, and harvesting light
for autonomous energy generation.1,3,4,9 They have been engi-
neered to be responsive to their environment,7 and as tools to
screen ion channel blockers,10 to study the effects of membrane
asymmetry,11 and to dynamically control the concentration of
embedded proteins on a membrane patch.12 Extended 3D
networks can be constructed using droplet microfluidics2,13,14
and droplet printing,15 and have been engineered to show
cooperative behaviours and possess tissue-like features.15
One inherent feature of DIBs is that they exist in a bulk oil
environment. This prevents their use in physiological (i.e.
aqueous) environments and has proved to be a bottleneck for
the use of DIBs for a range of potentially powerful applications,
for example, as compartmentalised drug delivery machines16 or
as biosensors. To address this, Villar et al. encapsulated several
lipid-stabilised water droplets in a larger oil-in-water droplet,
allowing a droplet network to operate in an aqueous environ-
ment.17 These structures, known as multisomes, were shown
to respond to both pH and temperature and could have protein
pores reconstituted in their membranes. Similarly, we have
previously generated analogous bilayer networks that do not
contain an intermediate oil phase, in the form of multi-
compartment vesicles.18,19 The use of these vesicles as spatially
segregated reactors that mimic cellular signalling cascades was
later shown.20
The major limitation of both these structures arises from
how they are generated: they are constructed by manually
pipetting individual droplets one-by-one. Droplet sizes are there-
fore restricted by the minimum pipetting volume, and are thus in
the mL volume regime. In addition, each unit has to be assembled
manually and individually, leading to a very low throughput
of formation, on the order of minutes per single structure.
This drastically limits their future applications. For compart-
mentalised membrane systems to be used as artificial cells, or
as soft-matter devices operating in physiological environments,
their characteristic dimensions need to be reduced, and their
generation throughput increased.
In this communication, we turn to droplet-basedmicrofluidics21
to provide a solution to this and to relieve the bottleneck. We
design and fabricate devices that generate multisomes, which
are an order of magnitude smaller (ca. 4 pL) and crucially, with
a generation throughput that is three orders ofmagnitude greater
(hundreds of multisomes generated per minute). We can also
control the number of droplets in the encapsulated network as
well as their content. We prove that there is a bilayer present via a
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diﬀusion assay, and demonstrate the potential of the structures
as in situ drug synthesis machines by synthesising a pharma-
cologically relevant chemical moiety in their interior.
To generate multisomes we fabricated a device that con-
sisted of two sequential droplet generation modules separated
by a meandering channel (Fig. 1 and ESI,† Video). The first
junction consisted of two opposing T-junctions with two diﬀerent
aqueous inlets, yielding water-in-oil (w/o) droplets of alternating
compositions. 25 mg ml1 of diphytanoylphosphatidylcholine
(DPhPC) lipid was dissolved in the oil phase, which self-assembled
as a monolayer around the droplets as they travelled through the
meander. This enabled bilayers to form at the droplet–droplet
interfaces, and prevented droplet coalescence upon encountering
the outer aqueous phase.
The second junction contained a flow-focusing channel geo-
metry, which encapsulated a set number of aqueous droplets in
larger oil droplets, producing double emulsion basedmultisomes.
This was followed by additional meandering and channel widening
where droplets were stored and monitored.
DIBs were formed between the multiple inner droplets
themselves, and between the inner droplets and the external
aqueous phase. Multisome dimensions and architecture were
predominately determined by the device geometry, with the inner
aqueous droplet and external oil droplet diameters regulated by
the characteristic dimensions of the first and second flow focusing
junctions respectively. Flow rates are a second-order determinant
of droplet size, with smaller droplets produced by increasing the
continuous phase flow.22 Likewise, flow rates of the segmented
phase aﬀect droplet generation frequencies. By increasing the
frequency at which the inner droplets were generated compared
to the outer droplets, multisomes with a larger number of inner-
compartments could be produced on the same device (see the
ESI,† Video). Droplet encapsulation number could thus be user-
defined, yielding multisomes with varying numbers of inner
droplets (between one and four, Fig. 1C).
Multisomes were generated at a rate of 300 per minute and
stored in channels (Fig. 1D). 95% encapsulation eﬃciency
was achieved; however, the emulsion survival rate stood at
Fig. 1 Microfluidic generation of multisomes. (A) Schematic of a multisome with bilayers present at all water–oil interfaces. (B) Schematic of a device and
corresponding brightfield images of different regions. First, alternating droplets of two different compositions are generated by two opposing T-junctions.
These travel through a meander, allowing time for monolayer stabilisation. Two such droplets are then encapsulated downstream in an oil droplet using a
flow-focusing channel geometry, generating two-droplet multisomess. (C) By altering the generation frequencies of the internal aqueous droplets, 1, 2, 3, and
4 compartment multisomes can be generated. (D) Monodisperse two-droplet multisomes with different inner droplet compositions stored in collection
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88% (n = 300) for two-compartment multisomes, with a propor-
tion of droplet pairsmerging shortly after formation. If individual
droplets were still intact after 30 seconds, they were stable for the
course of the experiments (60 minutes). An important factor in
multisome stability was the degree of confinement of the inner
droplets. Higher confinement led droplets to squeeze against each
other, exerting forces which increased the probability of bilayer
rupture. As three- and four-compartment multisomes are inher-
ently more confined, their survival rates were correspondingly
lower. Changing device geometry to decrease the confinement
(for example, to produce a larger intermediate oil droplet) would
be necessary to produce stable multisomes with more internal
compartments.
Average inner and outer droplet volumes were 1.56 pL (72 mm
radius) and 8.01 pL (128 mm radius) respectively, with the corres-
ponding coeﬃcients of variation of 3.4% and 1.5% (Fig. 1E).
Droplet volumes were therefore highly uniform, a common
feature associated with droplet-based microfluidic technologies.
The use of microfluidics therefore enables the generation of
compartmentalised membrane systems with finer size resolution
and an order of magnitude smaller volumes than can be reached
with pipetting. Further miniaturisation will allow cell-sized
dimensions to be reached (and surpassed), paving the way for
drug-delivery applications.
We then demonstrated the ability of multisomes to be used as
multi-compartment chemical microreactors via the synthesis of a
biologically relevant compound (Experimental details available in
the ESI†). We constructed multisomes consisting of two inner
droplets, which acted as modules in the chemical reactor: one
droplet acted as a chemical reservoir and the other as a reaction
chamber. We produced multisomes with two diﬀerent cargoes
contained in each of the encapsulated droplets. In one droplet,
a membrane impermeable fluorogenic pyrylium compound
(Chromeo P540)23 was encapsulated, and in the other a membrane
permeable primary amine (ethanolamine, HOCH2CH2NH2). The
amine-containing droplet acted as a reservoir, which steadily fed
the amine through the DIB into the adjacent droplet, in which a
chemical transformation took place (Fig. 2). Ethanolamine was
able to gradually diﬀuse through the bilayer due to its neutral
charge and small size (logP = 1.31).24 As the amine entered the
adjacent compartment, it reacted with pyrylium to yield a pyridi-
nium salt, which was fluorescent (ex = 533 nm, em = 627 nm, see
ESI†). A fluorescence increase in the adjacent compartment over
time was observed (Fig. 2B), with a gradual increase over a period
of 800 s before a plateau in fluorescence intensity as the reagent
was depleted. Fluorescence was not seen to decrease from its
maxima, and the surroundings exhibited no observable fluores-
cence increase. This suggests that the reaction product does not
leak into the oil or external water phase over the time course of
the experiment, most likely a result of the pyridinium positive
charge prohibiting translocation across the bilayer or partition-
ing into the oil phase.
Previous studies show that the rate determining step for the
reaction between pyrylium and analogous primary amines is
the intermediate ring closure to yield the pyridinium product
(k = 4.04  103 s1).25 The corresponding approximate reaction
completion timescales (B750 s) are comparable to the ones we
observe (B810 s). The fact that reaction times were not signifi-
cantly slower in our system indicates that the rate of ring
closure is comparable to, or faster than, diﬀusion across the
membrane.
In control experiments, identical multisomes were generated
but with no ethanolamine present. No fluorescence increase was
seen, showing that the reaction was not occurring due to external
sources of primary amine (originating, for example, from the
device fabrication process).
Together with the lack of fluorescence increase in the absence
of a bilayer, these experiments proved the existence of a DIB.
In addition, the results establish the applicability of such systems
for in situ drug synthesis, as the pyridinium reaction products
and their analogues are found in a wide range of medicinal and
agricultural products, including anaesthetics, antiprotozoals, and
antiallergenics.26,27 Their bioactivity and commercial use therefore
Fig. 2 Multisomes as reactors for on-board synthesis. (A) Reaction
scheme between pyrylium and a primary amine, yielding fluorescent
pyridinium. (B) Fluorescence intensity of the pyrylium-containing com-
partment over time. Error bars = one standard deviation, n = 5. The two
reagents were originally isolated in the two compartments. As ethanol-
amine diﬀused through the DIB, fluorescent pyridinium product was
formed. (C) Fluorescence/brightfield composite image of the reactor at
start, middle, and endpoints of experiment, showing gradual reactant
diﬀusion and reaction progression. Brightness and contrasts enhanced
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made them attractive candidates to be used as a proof-of-concept
for our system.
Although the above experiment demonstrates the use of multi-
somes for simple one-step reactions, by adding more compart-
ments this can be extended to multi-step chemical reactions, each
step being performed in distinct compartments.20 Furthermore,
the fact that it is possible to tune droplet sizes using simple
microfluidic engineering principles, and that droplet sizes in
turn determine bilayer area, raises the possibility of modulating
reaction kinetics using the architecture of the system.
These results demonstrate a new class of biomimetic
microreactors bearing advantages associated with sub-
compartmentalisation. Compartmentalisation allows isolated
specialised modules to be introduced, with more elaborate
operations introduced in the future, including waste droplets
and processing elements, allowing for greater complexity than
traditional uni-compartment systems. The system’s modular
nature also allows for multiple potentially interfering processes
(non-orthogonal reactions) to occur in a single droplet collection
by segregating them in space.
The presence of lipid bilayers between compartments renders
the multisomes generated here as distinct entities to conven-
tional double emulsions.28,29 Crucially, they provide an interface
through which reagent transfer can take place, and increase the
biomimetic potential of the structures enabling them to be used
for synthetic biology and biotechnology applications. The use of
membranes to delineate compartments allows functionalization
by biological components including transmembrane proteins,
mechanosensitive channels, and antibodies, as well as ensuring
biocompatibility. It also enables researchers to take advantage
of the varied biophysical behaviours of membranes, and to
exploit them to modulate processes—such as pore formation
with a change in temperature, electromagnetic radiation, or in
response to chemical stimulus—to yield smart and responsive
features. The above attributes provide an opportunity for the
design of dormant systems, which become active upon encoun-
tering set stimuli, with applications for in vivo drug synthesis
and delivery.
In conclusion by leveraging microfluidic technologies we were
able to scale-up the generation throughput of multisomes to
hundreds a minute, and scale down their size to the pL regime,
all while maintaining control over the number of droplets in the
encapsulated network and their content. This allows the power
and potential of droplet networks to be extended to an aqueous
setting. We also demonstrate the use of multisomes generated
via microfluidics as a platform to perform rudimentary synthetic
chemistry in a cell-like device, paving the way for the generation
of truly functional and responsive compartmentalised soft-
matter devices for a range of applications, including in situ
drug synthesis and as self-contained diagnostic devices.
Microfluidic technologies such as these could be used as an
enabling technology for synthetic biology, facilitating scale
up in generation throughput and scale down in size that is
needed for them to see functional use.
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